Financhill
Back

Legend Biotech Quote, Financials, Valuation and Earnings

Legend Biotech Price Quote

$45.22
-0.24 (-0.53%)
(Updated: October 30, 2024 at 2:25 PM ET)

Legend Biotech Key Stats

Sell
16
Legend Biotech (LEGN) is a Sell

Day range:
$44.56 - $45.90
52-week range:
$38.60 - $70.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.15
P/B ratio:
7.23%

Volume:
659.5K
Avg. volume:
1.3M
1-year change:
-28.6%
Market cap:
$8.4B
Revenue:
$285.1M
EPS:
$-1.54

How Much Does Legend Biotech Make?

Is Legend Biotech Growing As A Company?

  • What Is Legend Biotech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.54%
  • What Is Legend Biotech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Legend Biotech Stock Price Performance

  • Did Legend Biotech Stock Go Up Last Month?
    Legend Biotech share price went down by -7.73% last month
  • Did LEGN's Share Price Rise Over The Last Year?
    LEGN share price fell by -28.6% over the past 1 year

What Is Legend Biotech 52-Week High & Low?

Legend Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Legend Biotech?

  • How Much Debt Does Legend Biotech Have?
    Total long term debt quarterly is $291.6M
  • How Much Cash Does Legend Biotech Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Legend Biotech’s Book Value Per Share?
    Book value per share is 6.33

Is Legend Biotech Cash Flow Positive?

  • What Is LEGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$142.6M
  • What Is Legend Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.7M
  • What Is Legend Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$893.3M

Legend Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    LEGN return on invested capital is -18.44%
  • What Is Legend Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is -15.5%
  • What Is LEGN Return On Equity?
    ROE is a measure of profitability and is -22.55%

Legend Biotech Earnings Date & Stock Price

Legend Biotech Competitors

  • Who Are Legend Biotech's Competitors?
    Below is a list of companies who compete with Legend Biotech or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • BioCryst Pharmaceuticals Inc (BCRX)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Johnson & Johnson (JNJ)
    • National Healthcare Corp (NHC)

Legend Biotech Dividend Yield

Legend Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 75.98%
Revenue: 154.36% 47.91%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 83.15
Upside from Last Price: 82.91%

Major Shareholders

  • How many LEGN shares are owned by institutional investors?
    181.8M LEGN shares are owned by institutional investors
  • How many LEGN shares are owned by insiders?
    0 LEGN shares are owned by insiders